dexmedetomidine has been researched along with Cancer of Ovary in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Gao, C; Jiang, Z; Wang, S; Xie, YH; Zhang, JP; Zhang, N; Zhang, W; Zhou, Y | 1 |
| Jia, R; Zhao, J; Zheng, L | 1 |
| Cheng, Q; Hou, L; Tian, H; Xiong, Y | 1 |
| Cai, QH; Fan, SH; Huang, SQ; Li, H; Lu, J; Tang, Y; Wu, DM; Zhang, ZF; Zheng, YL | 1 |
| Kang, Y; Ni, J; Wu, L | 1 |
| Cheng, Q; Hou, L; Huang, J; Tian, H; Xiong, Y | 1 |
6 other study(ies) available for dexmedetomidine and Cancer of Ovary
| Article | Year |
|---|---|
Efficacy of dexmedetomidine as an adjunct to ropivacaine in bilateral dual-transversus abdominis plane blocks in patients with ovarian cancer who underwent cytoreductive surgery.
Topics: Abdominal Muscles; Adult; Aged; Anesthetics, Local; Cytoreduction Surgical Procedures; Dexmedetomidine; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Nerve Block; Ovarian Neoplasms; Pain, Postoperative; Ropivacaine; Treatment Outcome | 2022 |
Dexmedetomidine Regulates Proliferation, Apoptosis, Migration, and Invasion in Ovarian Cancer Cells via MiR-155-HIF-1α Axis.
Topics: Apoptosis; Base Sequence; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dexmedetomidine; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; MicroRNAs; Neoplasm Invasiveness; Ovarian Neoplasms; Signal Transduction; Up-Regulation | 2019 |
Dexmedetomidine upregulates microRNA-185 to suppress ovarian cancer growth via inhibiting the SOX9/Wnt/β-catenin signaling pathway.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Cell Line, Tumor; Cell Proliferation; Dexmedetomidine; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Ovarian Neoplasms; SOX9 Transcription Factor; Up-Regulation; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2021 |
In vivo effects of dexmedetomidine on immune function and tumor growth in rats with ovarian cancer through inhibiting the p38MAPK/NF-κB signaling pathway.
Topics: Animals; Apoptosis; Blotting, Western; Cell Proliferation; Dexmedetomidine; Dose-Response Relationship, Drug; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Female; Hypnotics and Sedatives; Interleukin-2; NF-kappa B; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Inbred F344; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha | 2017 |
Dexmedetomidine sedation combined with epidural anesthesia for laparoscopy in a patient with suspected tuberculosis: A case report.
Topics: Anesthesia, Epidural; Carcinoma; Dexmedetomidine; Diagnosis, Differential; Diagnostic Techniques, Obstetrical and Gynecological; Female; Humans; Hypnotics and Sedatives; Laparoscopy; Middle Aged; Ovarian Neoplasms; Tuberculosis, Female Genital | 2018 |
Effect of Dexmedetomidine-Mediated Insulin-Like Growth Factor 2 (IGF2) Signal Pathway on Immune Function and Invasion and Migration of Cancer Cells in Rats with Ovarian Cancer.
Topics: Animals; Cell Movement; Dexmedetomidine; Female; Insulin-Like Growth Factor II; Interleukin-2; Neoplasm Invasiveness; NF-kappa B; Ovarian Neoplasms; Rats; Rats, Inbred F344; Signal Transduction; Tumor Necrosis Factor-alpha | 2019 |